This Draft Assessment Explained for Students (Easy Guide)

This type of question evaluates analytical and critical thinking skills.

What This Question Is About

This question relates to this draft assessment and requires a structured academic response.

How to Approach This Question

Use appropriate theories and support your answer with clear reasoning.

Key Explanation

This topic involves this draft assessment. A strong answer should include explanation, application, and examples.

Original Question

This is my draft of the assessment so far, can you please add to it on any points that I have missed for these questions. I also need references. PARA2001: Integrated Clinical Case Describe specifically the pathophysiological changes occurring in COPD that result in each of the signs or symptoms listed in Table 2, and the observations listed in table 1 (ie detail what pathophysiological change is responsible for each sign or symptom and observation). (20 marks; note – separate marks are allocated for each element) Breathlessness – Chronic inflammation and structural alterations (fibrosis, destruction of the alveolar wall) lessen lung elasticity and narrow airways in COPD, resulting in airflow restriction and hyperinflation that hinder gas exchange and increase the effort required to breathe. Dyspnea arises as the respiratory muscles try to overcome this obstruction (Barnes, 2016). Cough – A defining feature of chronic bronchitis (a COPD phenotype), cough is brought on by mucus hypersecretion and airway irritation from long-term exposure to cigarette smoke. Goblet cell hyperplasia and impaired mucociliary clearance further prolong coughing. https://pmc.ncbi.nlm.nih.gov/articles/PMC4951627/ Chest tightness – This sensation is caused by dynamic hyperinflation due to air trapping, which prevents the lungs from completely exhaling before the next breath begins, resulting in overdistension of alveoli and intercostal strain (O’Donnell et al., 2006).. In the case study it states “The recent hour and the previous two days have become worse” An acute exacerbation, frequently brought on by an illness or toxins, is described here. Bronchospasm and inflammation exacerbate airflow restriction, which quickly worsens dyspnea (Wedzicha & Seemungal, 2007). One barrel chest mark – A barrel-shaped thorax is indicative of long-term hyperinflation of the lungs. Due to trapped air, the diaphragm flattens, and the chest wall extends anteriorly and posteriorly, reducing lung compliance (Pauwels et al., 2001). Very quiet breath sounds – In patients with severe COPD, airflow may be so low it’s hardly audible (GOLD, 2023). Occasional wheeze – Wheezing is caused by turbulent airflow through narrowed airways due to bronchospasm or mucus plugging, especially during expiration (West, 2012). Little chest wall movement – The chest wall has reduced excursion during respiration due to diaphragmatic flattening and reliance on accessory muscles. Ventilatory mechanics are inefficient (West, 2012). Pulmonary hypertension and right ventricular failure are caused by chronic hypoxia and pulmonary vasoconstriction, which raise central venous pressure (Nauser & Stites, 2001). Elevated jugular veins – This indicates right-sided heart strain or cor pulmonale. Severe tachypnea is caused by hypoxia and increased work of breathing, and the body makes up for this by increasing rate to maintain oxygenation (West, 2012). Heart rate 120 – Tachycardia is a response to hypoxia and sympathetic stimulation. It aims to increase cardiac output and oxygen delivery to tissues (Guyton & Hall, 2021). Blood pressure 95/50 – Hypotension may reflect systemic vasodilation, hypoxia-induced cardiac dysfunction, or fatigue of compensatory mechanisms (Khouzam, 2014). SpO2 82% – This is significant hypoxaemia due to V/Q mismatch and alveolar destruction. Oxygen cannot effectively diffuse across thickened alveolar walls or reach poorly ventilated areas (GOLD, 2023). GCS 13 – A mildly reduced GCS may result from hypoxia or hypercapnia (COâ‚‚ narcosis). Elevated COâ‚‚levels affect cerebral blood flow and mental status (West, 2012). Discuss why you would administer salbutamol and describe how it works at the cellular level. (10 marks) Salbutamol is a short-acting beta-2 adrenergic receptor agonist (SABA) that is used to treat bronchospasm. In patients with COPD, inflammation and bronchoconstriction reduce airflow, so salbutamol relaxes smooth muscle in the bronchial walls, improving ventilation. Cellular Mechanism: Salbutamol binds to β2-receptors on airway smooth muscle, activating adenylate cyclase ïƒ raising cAMP, which in turn activates protein kinase A and inhibits myosin light-chain kinase, causing smooth muscle relaxation and bronchodilation (Barnes, 2016). It also helps mucociliary clearance by raising ciliary beat frequency, which reduces symptoms and improves oxygenation. Discuss why they would take an arterial blood gas and explain what the results mean and how they are influenced by the underlying pathophysiology of Mr Wenham’s condition. (10 marks) Arterial blood gases (ABGs) are taken to assess Mr. Wenham’s oxygenation, ventilation, and acid-base status. The results (pH 7.12, PaO2 100 mmHg, PaCO2 110 mmHg, HCO3 38) indicate acute respiratory acidosis due to CO2 retention, a common occurrence in COPD exacerbations. The high PaCO2 reflects inadequate ventilation, leading to elevated carbon dioxide levels. The compensatory bicarbonate level (HCO3 38) indicates the kidneys are attempting to buffer the acidosis, but the acute nature of the respiratory failure complicates this (Neder et al., 2021). ADD MORE HERE Overview the normal physiological control of breathing (not the mechanics of ventilation) (5 marks). Then, explain how carbon dioxide retention might occur when COPD patients are receiving supplemental oxygen (11 marks). How would you recognise this if it was happening to Mr Wenham (4 marks)? (20 marks overall) The physiological control of breathing is primarily regulated by the central nervous system, involving chemoreceptors that detect changes in carbon dioxide (CO2), oxygen (O2), and pH levels in the blood. Central chemoreceptors in the medulla oblongata respond to rising CO2 levels, stimulating increased respiratory rate and depth. Peripheral chemoreceptors located in the carotid and aortic bodies respond primarily to low O2 levels (Neder et al., 2021). When COPD patients receive supplemental oxygen, there is a risk of carbon dioxide retention. In these patients, the hypoxic drive (the body’s reliance on low oxygen levels to stimulate breathing) can be diminished, leading to a reduced respiratory drive. As a result, CO2 can accumulate, leading to hypercapnia (Matera et al., 2021). If Mr. Wenham were experiencing CO2 retention, signs would include worsening confusion, lethargy, increased somnolence, and potentially a decrease in respiratory effort (Walters et al., 2021). ADD MORE When considering his blood gas analysis, do you think it is a good idea to remove Mr Wenham’s oxygen and have him just breathing air? Provide an argument supporting why it is OR why it is not. (10 marks) No. Although too much oxygen can exacerbate hypercapnia, hypoxia is more dangerous right away. Based on COPD guidelines, Mr. Wenham’s initial SpO was 82%; removing oxygen could result in severe hypoxia. Given Mr. Wenham’s blood gas analysis, it is not advisable to remove his oxygen entirely. While the risk of CO2 retention exists, the acute hypoxemia he is experiencing necessitates supplemental oxygen to prevent tissue hypoxia. Best Practice: Titrate oxygen to SpO 88-92%; abrupt withdrawal increases the risk of hypoxemia, cardiac arrhythmia, or death (O’Driscoll et al., 2017). An appropriate approach would be to titrate the oxygen to achieve adequate saturation levels without excessively raising PaO2, as further increases in oxygen could worsen CO2 retention (Matera et al., 2021). Use ABGs to guide oxygen therapy titrations. What is BiPAP? How might BiPAP help to improve Mr Wenham’s clinical condition? (10 marks) BiPAP (Bilevel Positive Airway Pressure) is a non-invasive ventilation method that delivers two levels of airway pressure: Inspiratory Positive Airway Pressure (IPAP), which reduces the effort needed to breathe, and Expiratory Positive Airway Pressure (EPAP), which prevents airway collapse. In patients with COPD, such as Mr. Wenham, BiPAP improves alveolar ventilation, reduces COâ‚‚ retention, relieves respiratory muscle fatigue, and supports gas exchange, thereby helping to manage respiratory failure and potentially avoiding the need for intubation (Plant et al., 2000; Neder et al., 2021). What is spirometry and what is it used for? (5 marks) Spirometry is a pulmonary function test used to assess lung function by measuring the volume and flow of air during inhalation and exhalation. It specifically measures Forced Expiratory Volume in 1 second (FEV₁) and Forced Vital Capacity (FVC), with the FEV₁/FVC ratio indicating the presence of airflow obstruction. This test is essential for diagnosing conditions like asthma and COPD, tracking disease progression, and evaluating treatment effectiveness (GOLD, 2023; Matera et al., 2021). ADD MORE HERE Discuss the significance of the results by examining the differences between Mr Wenham’s spirometry and that of a normal individual. (10 marks) Mr. Wenham’s spirometry results – FEV₁ of 0.75 L, FVC of 1.5 L, and an FEV₁/FVC ratio of 50% – indicate a moderate-to-severe obstructive pattern consistent with GOLD stage II-III COPD. This reflects significant airflow limitation due to airway narrowing, mucus buildup, and alveolar loss. In a healthy individual, the FEV₁/FVC ratio is typically above 70%; the reduced values here confirm both the diagnosis of COPD and ongoing functional impairment despite therapy (Walters et al., 2021). How does the pathology of COPD explain these differences in spirometry? (5 marks) The pathology of COPD explains Mr. Wenham’s spirometry results through chronic inflammation and smoking-related damage to the airways and alveoli. This destruction leads to narrowed bronchi, increased airway resistance, and loss of elastic recoil, which impairs airflow, especially during forced expiration. As a result, air trapping occurs, increasing functional residual capacity (FRC) and residual volume (RV), while reducing forced vital capacity (FVC). These changes lead to decreased FEV₁ and a reduced FEV₁/FVC ratio, consistent with obstructive lung disease (Barnes, 2016; Matera et al., 2021). REFERENCES

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."